Biodexa to host breakfast symposium on fap mechanisms and chemoprevention trial issues at cga – igc conference on october 11, 2025

October 6, 2025 biodexa to host breakfast symposium on fap mechanisms and chemoprevention trial issues at cga – igc conference on october 11, 2025 biodexa pharmaceuticals plc (“biodexa” or “the company”), (nasdaq: bdrx), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, will host a breakfast symposium at the collaborative group of the americas on inherited gastrointestinal cancer (cga-igc) annual meeting in st louis, mo on october 9-11, 2025. the symposium presentation, titled “fap mechanisms and chemoprevention trial issues” will be delivered by guest speaker dr patrick lynch md, professor of medicine (rtd), department of gastroenterology, hepatology and nutrition, university of texas md anderson cancer center.
CGA Ratings Summary
CGA Quant Ranking